<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01843296</url>
  </required_header>
  <id_info>
    <org_study_id>392022</org_study_id>
    <nct_id>NCT01843296</nct_id>
  </id_info>
  <brief_title>Effects of Addition of Magnesium Sulfate in Spinal Anesthesia on Sensory-Motor Blocks and Postoperative Pain in Lumbar Disk Herniation Surgery</brief_title>
  <official_title>Comparison of the Effects of Three Methods of Intrathecal Bupivacaine; Bupivacaine-Fentanyl and Bupivacaine-Fentanyl-Magnesium Sulfate on Sensory-Motor Blocks and Postoperative Pain in Patients Undergoing Lumbar Disk Herniation Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Isfahan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Isfahan University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to Compare three methods of intrathecal bupivacaine;
      bupivacaine-fentanyl; bupivacaine-fentanyl-magnesium sulfate on sensory-motor blocks and
      postoperative pain in patients undergoing lumbar disk herniation surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Comparison three methods of intrathecal
           bupivacaine;bupivacaine-fentanyl;bupivacaine-fentanyl-magnesium sulfate on sensory-motor
           blocks in patients undergoing lumbar disk herniation surgery

        -  Comparison three methods of intrathecal
           bupivacaine;bupivacaine-fentanyl;bupivacaine-fentanyl-magnesium sulfate on postoperative
           pain in patients undergoing lumbar disk herniation surgery

        -  Comparison three methods of intrathecal
           bupivacaine;bupivacaine-fentanyl;bupivacaine-fentanyl-magnesium sulfate on postoperative
           side effects in patients undergoing lumbar disk herniation surgery
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The onset of sensory block</measure>
    <time_frame>From intrathecal injection until the onset of sensory block assessed up to 15 minutes</time_frame>
    <description>Comparing the onset of sensory blocks to T10 (10th thoracic dermatome) assessed by pinprick test.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The complete motor block</measure>
    <time_frame>From intrathecal injection until the onset of complete motor block assessed up to 15 minutes</time_frame>
    <description>Time to complete motor block after intrathecal injection as assess using a modified Bromage scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The sensory block regression</measure>
    <time_frame>From intrathecal injection until the sensory block reression to (T10) assessed up to 6 hours</time_frame>
    <description>The sensory block regression to (T10) dermatome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The full motor recovery</measure>
    <time_frame>From intrathecal injection until the full motor recovery assessed up to 6 hours</time_frame>
    <description>Full motor recovery was defined as zero on the Bromage scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Pain Score</measure>
    <time_frame>The first 24 hours after spinal anesthesia</time_frame>
    <description>Using VAS (Visual Analogue Score) system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to first analgesic requirement</measure>
    <time_frame>During first 24 hours after spinal anesthesia</time_frame>
    <description>Time to first analgesic requirement was measured from the time of spinal injection to the first time at which the patient complained of pain in the postoperative period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Arterial Blood Pressure</measure>
    <time_frame>First hour after spinal anesthesia</time_frame>
    <description>To compare blood pressure alteration and hypotension between three groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>First hour after spinal anesthesia</time_frame>
    <description>To compare heart rate variation and bradycardia between three groups</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">105</enrollment>
  <condition>Lumbar Spine Disc Herniation</condition>
  <arm_group>
    <arm_group_label>Magnesium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in group C received a premixed solution of 15 mg hyperbaric bupivacaine 0.5% (3 ml) and 25 µg fentanyl (0.5cc) and 50 mg of magnesium sulfate 50% (0.1 ml) (Pasteur Institute Co, Tehran, Iran) for spinal anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in Fentanyl group received a premixed solution of of 15 mg hyperbaric bupivacaine 0.5% (3 ml) and 25 µg fentanyl (0.5cc),plus 0.1 cc preservative free 0.9% normal saline for spinal anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in Bupivacaine group(control) received a premixed solution of 15 mg of hyperbaric bupivacaine 0.5% (3 ml), plus 0.6 cc preservative free 0.9% normal saline for spinal anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate</intervention_name>
    <description>Injection of 50 mg of magnesium sulfate 50% (0.1 ml),intrathecally.</description>
    <arm_group_label>Magnesium</arm_group_label>
    <other_name>Magnesium sulfate 50%</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Spinal Anesthesia</intervention_name>
    <description>Lumbar puncture was performed in sitting position,at the one level above iliac crest. Using a median approach, a 25-G Quincke needle was introduced with the needle aperture directed laterally.</description>
    <arm_group_label>Magnesium</arm_group_label>
    <arm_group_label>Fentanyl</arm_group_label>
    <arm_group_label>Bupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <arm_group_label>Magnesium</arm_group_label>
    <arm_group_label>Fentanyl</arm_group_label>
    <arm_group_label>Bupivacaine</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <arm_group_label>Magnesium</arm_group_label>
    <arm_group_label>Fentanyl</arm_group_label>
    <other_name>Sublimaze</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Candidate for lumbar disk herniation surgery

          -  No contraindication to the spinal anesthesia

          -  No history of allergy to opioids and magnesium sulfate

          -  No peripheral or central neuropathies

          -  No previous history of surgery on same disk level

        Exclusion Criteria:

          -  Patients with intraoperative tearing of dural suc

          -  Occuring of inadvertent intraoperative complications such as bleeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammad Ali Attari, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Isfahan University of Medical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alzahra</name>
      <address>
        <city>Isfahan</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2013</study_first_submitted>
  <study_first_submitted_qc>April 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2013</study_first_posted>
  <last_update_submitted>June 30, 2013</last_update_submitted>
  <last_update_submitted_qc>June 30, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 2, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Isfahan University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Fereidoun Mortazavi Najafabadi, MD</investigator_full_name>
    <investigator_title>fellowship of neuroanesthesia</investigator_title>
  </responsible_party>
  <keyword>Spinal Anesthesia</keyword>
  <keyword>Bupivacaine</keyword>
  <keyword>Fentanyl</keyword>
  <keyword>Magnesium sulfate</keyword>
  <keyword>Postoperative Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Hernia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

